Payment overview · 2025
General Payments
$296.29
12 reported records · 4 companies
Healthcare provider profile · identity verified
Min Cai, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FLUSHING, NY · NPI 1003813676
Verified facts
What the public records show
CMS Open Payments records show Min Cai, M.D. received $296.29 in general payments during 2025 across 12 reported records.
ABBVIE INC. accounted for 33.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Linzess, Ozempic, Rybelsus, Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 427 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 247 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Synthroid by this doctor in 2024.
Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Vemlidy as an associated drug or biological on 782 records involving 554 distinct recipient NPIs. Public Medicare Part D data also shows 47 claims for Vemlidy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 110 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $99.15 | 33.5% | 4 | 2025 |
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $92.02 | 31.1% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $67.01 | 22.6% | 3 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $38.11 | 12.9% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $296.29 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CREON Normalized: creon |
Drug | ABBVIE INC. | $99.15 | 4 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $67.01 | 3 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $47.12 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $44.74 | 2 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $38.11 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 427 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 247 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 42 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 49 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 20 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
427 | 82 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
247 | 49 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| Gilead Sciences, Inc. Exact reporting entity; no affiliate inference |
2025 | Vemlidy open payments reported associated product |
CMS Open Payments — General Payments 782 supporting records · 554 recipient NPIs · example record 1234350906 |
Vemlidy · 2024 Exact normalized brand match · 1 Part D row |
47 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
110 | 73 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
42 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
49 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2552 | 368 |
| Amlodipine Besylate | Amlodipine Besylate | 2198 | 319 |
| Vascepa | Icosapent Ethyl | 1368 | 193 |
| Losartan Potassium | Losartan Potassium | 1314 | 182 |
| Simvastatin | Simvastatin | 995 | 137 |
| Metoprolol Succinate | Metoprolol Succinate | 992 | 146 |
| Tamsulosin Hcl | Tamsulosin Hcl | 918 | 139 |
| Metformin Hcl | Metformin Hcl | 825 | 116 |
| Zolpidem Tartrate | Zolpidem Tartrate | 792 | 275 |
| Diclofenac Epolamine | Diclofenac Epolamine | 725 | 130 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 724 | 234 |
| Levothyroxine Sodium | Levothyroxine Sodium | 696 | 95 |
| Omeprazole | Omeprazole | 673 | 209 |
| Alendronate Sodium | Alendronate Sodium | 611 | 91 |
| Ammonium Lactate | Ammonium Lactate | 524 | 170 |
| Clopidogrel | Clopidogrel Bisulfate | 499 | 72 |
| Raloxifene Hcl | Raloxifene Hcl | 499 | 69 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 468 | 93 |
| Montelukast Sodium | Montelukast Sodium | 453 | 146 |
| Jardiance | Empagliflozin | 440 | 58 |
| Donepezil Hcl | Donepezil Hcl | 439 | 66 |
| Creon | Lipase/Protease/Amylase | 427 | 82 |
| Famotidine | Famotidine | 420 | 121 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 402 | 53 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 397 | 94 |
| Fluticasone Propionate | Fluticasone Propionate | 396 | 166 |
| Finasteride | Finasteride | 392 | 55 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 392 | 166 |
| Xarelto | Rivaroxaban | 359 | 51 |
| Ketoconazole | Ketoconazole | 348 | 109 |
| Hydrochlorothiazide | Hydrochlorothiazide | 337 | 59 |
| Januvia | Sitagliptin Phosphate | 332 | 42 |
| Diclofenac Sodium | Diclofenac Sodium | 331 | 124 |
| Azithromycin | Azithromycin | 326 | 247 |
| Eliquis | Apixaban | 324 | 40 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 320 | 41 |
| Naproxen | Naproxen | 319 | 172 |
| Clobetasol Propionate | Clobetasol Propionate | 308 | 104 |
| Restasis | Cyclosporine | 308 | 49 |
| Atenolol | Atenolol | 301 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 292 | 43 |
| Halobetasol Propionate | Halobetasol Propionate | 273 | 84 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 261 | 39 |
| Meloxicam | Meloxicam | 257 | 136 |
| Celecoxib | Celecoxib | 248 | 88 |
| Linzess | Linaclotide | 247 | 49 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 247 | 34 |
| Mometasone Furoate | Mometasone Furoate | 247 | 65 |
| Carvedilol | Carvedilol | 226 | 36 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 224 | 44 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 220 | 32 |
| Trazodone Hcl | Trazodone Hcl | 219 | 57 |
| Gemfibrozil | Gemfibrozil | 217 | 29 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 212 | 29 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 209 | 37 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 202 | 86 |
| Fenofibrate | Fenofibrate | 199 | 27 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 198 | 20 |
| Folic Acid | Folic Acid | 185 | 31 |
| Loperamide | Loperamide Hcl | 185 | 126 |
| Allopurinol | Allopurinol | 183 | 25 |
| Enalapril Maleate | Enalapril Maleate | 183 | 22 |
| Mupirocin | Mupirocin | 182 | 96 |
| Gabapentin | Gabapentin | 179 | 58 |
| Glipizide Er | Glipizide | 178 | 27 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 177 | 37 |
| Hydrocortisone | Hydrocortisone | 177 | 50 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 171 | 56 |
| Meclizine Hcl | Meclizine Hcl | 164 | 102 |
| Azelastine Hcl | Azelastine Hcl | 163 | 50 |
| Pravastatin Sodium | Pravastatin Sodium | 147 | 25 |
| Farxiga | Dapagliflozin Propanediol | 142 | 21 |
| Icosapent Ethyl | Icosapent Ethyl | 142 | 50 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 141 | 47 |
| Clonazepam | Clonazepam | 136 | 33 |
| Alcohol Pads | Alcohol Antiseptic Pads | 128 | 41 |
| Bepotastine Besilate | Bepotastine Besilate | 127 | 33 |
| Entecavir | Entecavir | 122 | 15 |
| Propranolol Hcl | Propranolol Hcl | 121 | 18 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 118 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 116 | 21 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 112 | 27 |
| Mesalamine | Mesalamine | 110 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 110 | 73 |
| Glimepiride | Glimepiride | 109 | 15 |
| Ibuprofen | Ibuprofen | 108 | 79 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 107 | 107 |
| Ranolazine Er | Ranolazine | 104 | 15 |
| Tresiba Flextouch U-200 | Insulin Degludec | 103 | 12 |
| Lisinopril | Lisinopril | 102 | 19 |
| Methimazole | Methimazole | 102 | 14 |
| Dexlansoprazole Dr | Dexlansoprazole | 100 | 25 |
| Glipizide | Glipizide | 96 | suppressed |
| Kerendia | Finerenone | 92 | 15 |
| Pantoprazole Sodium | Pantoprazole Sodium | 92 | 27 |
| Trulicity | Dulaglutide | 91 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 89 | 14 |
| Spironolactone | Spironolactone | 89 | 12 |
| Nitroglycerin | Nitroglycerin | 86 | 50 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 83 | 70 |
| Doxazosin Mesylate | Doxazosin Mesylate | 83 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 80 | 16 |
| Tacrolimus | Tacrolimus | 80 | 20 |
| Benazepril Hcl | Benazepril Hcl | 78 | 12 |
| Nebivolol Hcl | Nebivolol Hcl | 77 | suppressed |
| Furosemide | Furosemide | 76 | 21 |
| Ursodiol | Ursodiol | 76 | 13 |
| Fluocinonide | Fluocinonide | 75 | 40 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 75 | 18 |
| Ramipril | Ramipril | 72 | suppressed |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 72 | 14 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 68 | 49 |
| Febuxostat | Febuxostat | 68 | suppressed |
| Niacin Er | Niacin | 68 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 66 | suppressed |
| Baclofen | Baclofen | 65 | 34 |
| Fenofibrate | Fenofibrate Nanocrystallized | 63 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 62 | 50 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 60 | 24 |
| Procto-Med Hc | Hydrocortisone | 60 | 21 |
| Symbicort | Budesonide/Formoterol Fumarate | 60 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 59 | 12 |
| Irbesartan | Irbesartan | 58 | suppressed |
| Nifedipine Er | Nifedipine | 57 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 56 | suppressed |
| Tradjenta | Linagliptin | 55 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 54 | 22 |
| Telmisartan | Telmisartan | 54 | suppressed |
| Valsartan | Valsartan | 54 | 11 |
| Lorazepam | Lorazepam | 53 | 15 |
| Acarbose | Acarbose | 52 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 52 | 43 |
| Metoclopramide Hcl | Metoclopramide Hcl | 50 | 35 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 50 | 48 |
| Entresto | Sacubitril/Valsartan | 49 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 49 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 49 | suppressed |
| Rybelsus | Semaglutide | 49 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 48 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 47 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 46 | 19 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 46 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Levofloxacin | Levofloxacin | 44 | 40 |
| Paxlovid | Nirmatrelvir/Ritonavir | 44 | 43 |
| Prednisone | Prednisone | 44 | 27 |
| Sucralfate | Sucralfate | 44 | 25 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 42 | 38 |
| Ozempic | Semaglutide | 42 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 41 | suppressed |
| Ezetimibe | Ezetimibe | 40 | suppressed |
| Lactulose | Lactulose | 40 | 14 |
| Latanoprost | Latanoprost | 40 | suppressed |
| Amoxicillin | Amoxicillin | 39 | 36 |
| Memantine Hcl | Memantine Hcl | 39 | suppressed |
| Xiidra | Lifitegrast | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 37 | suppressed |
| Synthroid | Levothyroxine Sodium | 37 | suppressed |
| Ciclopirox | Ciclopirox | 35 | 12 |
| Clonidine Hcl | Clonidine Hcl | 35 | suppressed |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 35 | suppressed |
| Oxiconazole Nitrate | Oxiconazole Nitrate | 34 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | suppressed |
| Acyclovir | Acyclovir | 33 | 11 |
| Cyclosporine | Cyclosporine | 32 | 14 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 32 | 22 |
| Prolia | Denosumab | 31 | 19 |
| Calcitriol | Calcitriol | 30 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 30 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 30 | 11 |
| Alogliptin-Metformin | Alogliptin Benz/Metformin Hcl | 29 | suppressed |
| Alprazolam | Alprazolam | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 28 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Metronidazole | Metronidazole | 26 | 22 |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Clobetasol Emollient | Clobetasol Propionate/Emoll | 25 | suppressed |
| Colchicine | Colchicine | 25 | 13 |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 25 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | 11 |
| Repaglinide | Repaglinide | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 24 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 24 | 11 |
| Dapagliflozin | Dapagliflozin Propanediol | 24 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 24 | 22 |
| Felodipine Er | Felodipine | 24 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 24 | suppressed |
| Multaq | Dronedarone Hcl | 24 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 24 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 23 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 20 |
| Zenpep | Lipase/Protease/Amylase | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 21 |
| Incruse Ellipta | Umeclidinium Bromide | 22 | suppressed |
| Lidocaine | Lidocaine | 22 | 11 |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 22 | suppressed |
| Indomethacin | Indomethacin | 21 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 21 | suppressed |
| Proctozone-Hc | Hydrocortisone | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 19 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Diflorasone Diacetate | Diflorasone Diacetate | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Potassium Chloride | Potassium Chloride | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Comfort Touch Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 16 | 16 |
| Pentoxifylline | Pentoxifylline | 16 | suppressed |
| Benzonatate | Benzonatate | 15 | 11 |
| Clemastine Fumarate | Clemastine Fumarate | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Livalo | Pitavastatin Calcium | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | 13 |
| Alogliptin | Alogliptin Benzoate | 14 | suppressed |
| Belsomra | Suvorexant | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Easy Comfort Alcohol Pad | Alcohol Antiseptic Pads | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 14 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Desoximetasone | Desoximetasone | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Meloxicam | Meloxicam, Submicronized | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | suppressed |
| Constulose | Lactulose | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Invokamet Xr | Canagliflozin/Metformin Hcl | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 12 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 12 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 12 | suppressed |
| Toprol Xl | Metoprolol Succinate | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Denta 5000 Plus | Fluoride (Sodium) | 11 | suppressed |
| Dexilant | Dexlansoprazole | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $296.29 · 12 records | ABBVIE INC. | CREON, LINZESS, Ozempic, Rybelsus, TRELEGY ELLIPTA | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error